National Drug Strategy
National Drug Strategy

National Buprenorphine Policy

Print page  Decrease text size  Increase text size

The National Buprenorphine Policy provides a broad policy context and a framework for State and Territory policies and guidelines. The policy outlines treatment issues in regard to the prescribing and dispensing of buprenorphine.

Prepared by the Intergovernmental Committee on Drugs (IGCD) sub-committee, Methadone and Other Treatments
Published by AusInfo for Commonwealth Department of Health and Aged Care
March 2001

National Buprenorphine Policy (PDF 143 KB)

Page currency, Latest update: 08 June, 2001

If you are having difficulty downloading the PDF document(s) please email phd.webmaster@health.gov.au and we will arrange for an alternative format or a copy to be sent to you.

Get Acrobat ReaderTo view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. The Adobe Acrobat Reader is available free of charge from Adobe's website.